Related by context. Frequent words. (Click for all words.) 76 VEGFR2 inhibitor 74 refractory chronic lymphocytic 74 overactive bladder AA# 74 DNA methyltransferase inhibitors 73 PNP inhibitor 73 Auxilium transmucosal film 73 oncolytic virus therapies 73 candidate ridaforolimus 72 oral proteasome inhibitor 72 Initiates Phase II 72 Panzem R 72 signal detection CTSD 72 MKC# MT 71 Completes Patient Enrollment 71 MKC# 71 2 methoxyestradiol 71 oral isoform selective HDAC 70 orBec ® oral beclomethasone 70 Emergent marketed 70 Daclizumab 70 YOUR LOCAL ANIMAL SHELTER 70 inflammatory autoimmune diseases 70 XL# XL# XL# XL# 69 Meets Primary Endpoint 69 Receives Orphan Drug Designation 69 triple VEGF receptor 69 Annamycin 69 Medarex applies 69 R sorafenib tablets 69 Romidepsin 69 XL# XL# 68 Copegus R 68 Empatic TM 68 Archexin 68 Dyax logo 68 phenylalanine ammonia lyase 68 Omacetaxine 68 KNS # 68 sorafenib tablets 68 FOLOTYN ® 68 ALN PCS 68 Presents Positive 68 ® bortezomib 67 fibrosis IPF 67 Panzem R NCD 67 generation Hsp# inhibitor 67 D aspartate NMDA receptor 67 developing Zerenex TM 67 AVN# [001] 67 Vytorin combines 67 Belimumab 67 BiovaxID TM 67 PEG PAL PEGylated recombinant 67 addressing idiopathic pulmonary 67 peripherally acting 67 proteasome inhibitor 67 PDE4 inhibitor 67 Medarex logo 67 orally bioavailable 66 Serdaxin ® 66 Thiarabine 66 * Azixa 66 development diagnostics combinatorial 66 topical non steroidal 66 sodium Injection 66 huC# DM4 66 ART# 66 mild vasodilator 66 immunotherapeutic agent 66 Phase Ib clinical trials 66 ZFP Therapeutics 66 Commences Phase 66 GVAX R 66 Idera Pharmaceuticals develops 66 hepatitis C lupus 66 By Neil Osterweil 66 candidates bavituximab 66 cromolyn sodium 66 includes investigational compounds 66 Sapacitabine 66 RhuDex ® 66 HOW LONG WAS 66 CCX# 66 investigational pan BCR 66 R bortezomib 66 histone deacetylase HDAC inhibitor 66 Initiate Phase 66 Tesetaxel 66 Amgen discovers develops 65 FUSILEV ® 65 indications Cytokinetics 65 Completes Enrollment 65 Metastatic Melanoma 65 liposomal formulation 65 Darinaparsin 65 Inhalation Aerosol 65 candidate AP# 65 Epratuzumab 65 ALN TTR 65 based pretargeting methods 65 phenylketonuria PKU developed